Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions.

Molecular and cellular endocrinology - 30 Jun 2010

Handkiewicz-Junak Daria, Czarniecka Agnieszka, Jarzab Barbara

Abstract excerpt

Gene expression profiling shows that, by gene signature, the difference between BRAF-positive and BRAF-negative PTC is so distinct that BRAF-positive cancer may be regarded as a molecular subtype of papillary thyroid cancer (PTC). Since much enthusiasm surrounds the BRAF-oncogene as a molecular p...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Biomarkers, Tumor
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to ras Proteins

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 20138116
DOI: 10.1016/j.mce.2010.01.007

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20138116-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions.PMID 20138116Read ↗

Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications.Semantic proximity Read ↗

Prognostic utility of BRAF mutation in papillary thyroid cancer.Semantic proximity Read ↗

Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker InvestigationsSemantic proximity Read ↗

BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid CancerSemantic proximity Read ↗

The relation between BRAFV600E mutation and clinicopathological characteristics of papillary thyroid cancer.Semantic proximity Read ↗

Analysis of the association of BRAFV600E mutation and Ki-67 overexpression with clinical and pathological characteristics in papillary thyroid cancer.Semantic proximity Read ↗

Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features.Semantic proximity Read ↗

Molecular Testing Based Assessment of the Potential Aggressiveness of Papillary Thyroid CarcinomaSemantic proximity Read ↗

Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma.Semantic proximity Read ↗

BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review).Semantic proximity Read ↗

BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrenceSemantic proximity Read ↗

Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangementsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.